The glycosaminoglycan-binding domain of decoy receptor 3 is essential for induction of monocyte adhesion.

作者: Yung-Chi Chang , Yueh-Hsuan Chan , David G. Jackson , Shie-Liang Hsieh

DOI: 10.4049/JIMMUNOL.176.1.173

关键词:

摘要: Decoy receptor 3 (DcR3), a soluble for Fas ligand, LIGHT (homologous to lymphotoxins shows inducible expression and competes with HSV glycoprotein D herpes virus entry mediator, expressed by T lymphocytes), TNF-like molecule 1A, is highly in cancer cells tissues affected autoimmune disease. DcR3.Fc has been shown stimulate cell adhesion modulate activation differentiation triggering multiple signaling cascades that are independent of its three known ligands. In this study we found DcR3.Fc-induced was inhibited heparin heparan sulfate, unable bind Chinese hamster ovary K1 mutants defective glycosaminoglycan (GAG) synthesis. Furthermore, the negatively charged, sulfated GAGs surface proteoglycans, but not their core proteins, were identified as binding sites DcR3.Fc. A potential GAG-binding site C-terminal region DcR3, mutation basic residues, i.e., K256, R258, R259, alanines abolished ability trigger adhesion. Moreover, fusion protein comprising DcR3 an Fc fragment (DcR3_HBD.Fc) same effect activating kinase C inducing Compared wild-type THP-1 cells, induced significantly reduced both CD44v3 syndecan-2 knockdown cells. Therefore, propose model which may cross-link proteoglycans induce monocyte

参考文章(48)
Fotini N Lamari, Anders Hjerpe, Nikos K Karamanos, Achilleas D Theocharis, Theodore Tsegenidis, Stavros Anagnostides, Evdokia Makatsori, Large matrix proteoglycans, versican and perlecan, are expressed and secreted by human leukemic monocytes. Anticancer Research. ,vol. 23, pp. 3303- 3309 ,(2003)
M. Roghani, A. Mansukhani, P. Dell'Era, P. Bellosta, C. Basilico, D.B. Rifkin, D. Moscatelli, Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. Journal of Biological Chemistry. ,vol. 269, pp. 3976- 3984 ,(1994) , 10.1016/S0021-9258(17)41730-3
Avi Ashkenazi, Wolfgang Wick, Hiroko Ohgaki, Mathias Bähr, Stefan Isenmann, Michael Platten, Michael Weller, Mitsutoshi Nakamura, Paul Kleihues, Wilfried Roth, Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Research. ,vol. 61, pp. 2759- 2765 ,(2001)
Robert M. Pitti, Scot A. Marsters, David A. Lawrence, Margaret Roy, Frank C. Kischkel, Patrick Dowd, Arthur Huang, Christopher J. Donahue, Steven W. Sherwood, Daryl T. Baldwin, Paul J. Godowski, William I. Wood, Austin L. Gurney, Kenneth J. Hillan, Robert L. Cohen, Audrey D. Goddard, David Botstein, Avi Ashkenazi, Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer Nature. ,vol. 396, pp. 699- 703 ,(1998) , 10.1038/25387
Tsui-Ling Hsu, Yung-Chi Chang, Siu-Ju Chen, Yong-Jun Liu, Allen W. Chiu, Chung-Ching Chio, Lieping Chen, Shie-Liang Hsieh, Modulation of Dendritic Cell Differentiation and Maturation by Decoy Receptor 3 Journal of Immunology. ,vol. 168, pp. 4846- 4853 ,(2002) , 10.4049/JIMMUNOL.168.10.4846
Eok-Soo Oh, John R. Couchman, Anne Woods, SERINE PHOSPHORYLATION OF SYNDECAN-2 PROTEOGLYCAN CYTOPLASMIC DOMAIN Archives of Biochemistry and Biophysics. ,vol. 344, pp. 67- 74 ,(1997) , 10.1006/ABBI.1997.0180
Francesc Granés, Raquel Garcı́a, Ricardo P. Casaroli-Marano, Susanna Castel, Natividad Rocamora, Manuel Reina, Jesús M. Ureña, Senén Vilaró, Syndecan-2 Induces Filopodia by Active cdc42Hs Experimental Cell Research. ,vol. 248, pp. 439- 456 ,(1999) , 10.1006/EXCR.1999.4437
C. Bai, B. Connolly, M. L. Metzker, C. A. Hilliard, X. Liu, V. Sandig, A. Soderman, S. M. Galloway, Q. Liu, C. P. Austin, C. T. Caskey, Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 1230- 1235 ,(2000) , 10.1073/PNAS.97.3.1230